文献速递乳腺癌

第8版AJCC分期在乳腺黏液腺癌中的预测价值

[The predicting value of the 8th edition of American Joint Committee on Cancer staging manual in mucinous breast cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

该研究纳入3628例接受根治性手术的单纯型乳腺黏液腺癌(PMBC)患者,比较第8版AJCC解剖学分期(AS)与预后分期(PS)的预后预测能力。结果显示两种分期均与乳腺癌特异性生存(BCSS)相关,但PS在预测预后方面并不优于AS。

要点

  • 第8版AJCC的AS和PS均是PMBC患者的预后影响因素。
  • PS较AS使37.54%患者分期改变,但预测能力未提升。
  • AS与PS的C-index分别为0.72和0.73,差异无统计学意义。

核心结论

  • 第8版AJCC分期中的AS和PS均是PMBC患者预后的影响因素,但与AS相比,PS并无更强的预后预测能力。

研究设计与样本

  • 回顾性收集3628例接受根治性手术的PMBC患者的临床和随访资料。
  • 比较不同分期患者的乳腺癌特异性生存(BCSS),采用似然比卡方、AIC和C-index评估AS与PS的预后价值。

主要发现

  • 在PMBC中,肿瘤大小(P=0.002)、淋巴结状态(P=0.002)、组织学分级(P=0.003)、孕激素状态(P=0.017)及是否接受辅助放疗(P=0.040)与BCSS有关。
  • 与AS相比,1326例(37.54%)患者的PS发生改变,其中分期上升和分期下降的患者分别占总人群的6.50%和31.04%。
  • AS和PS各期患者的BCSS差异均有统计学意义(均P<0.001)。
  • AS模型和PS模型的LR χ(2)分别为16.41和17.50,差异无统计学意义(P=0.296);AIC分别为357.44和358.35;C-index分别为0.72和0.73,差异无统计学意义(P=0.667)。

临床怎么用

  • 在PMBC患者中,第8版AJCC的AS与PS均可用于预后分层,但PS未显示优于AS的预测能力,临床可结合AS进行评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: The current study aimed to evaluate the predictive performances of anatomic staging system (AS) and prognostic staging system (PS) proposed in the 8th edition American Joint Committee on Cancer (AJCC) staging manual in patients with pure mucinous breast cancer (PMBC). Methods: Clinicopathologic features and follow-up information were collected from a total of 3628 patients with PMBC. Breast cancer-specific survival (BCSS) were compared among patients in different stage groups. Likelihood ratio (LR) χ(2), Akaike information criterion (AIC) and Harrell's concordance index (C-index) were used to evaluate the predictive performances of AS and PS in PMBC. Results: In PMBC, BCSS was associated with tumor size (P=0.002), lymph node status (P=0.002), grade(P=0.003), PR status(P=0.017)and the receipt of radiation. Compared to AS, 1326 patients (37.54%) underwent stage change after applying PS, with 6.50% upstaged and 37.04% downstaged. There were significant differences in BCSS among patients of different stages under the AS and PS (P<0.001). However, PS was not superior to AS in predicting prognosis (AS vs PS, LR χ(2): 16.41 vs 17.5; AIC: 357.44 vs 358.35; C-index, 0.72 vs 0.73, P=0.667). Conclusions: Both of AS and PS proposed in the 8th edition American Joint Committee on Cancer (AJCC) staging manual were predictive factors in patients with PMBC. Compared with AS, the PS did not show superiority in prognosis prediction among patients with PMBC. 目的: 分析和评估第8版美国癌症联合委员会(AJCC)分期系统提出的解剖学分期(AS)和预后分期(PS)两种分期方式在单纯型乳腺黏液腺癌(PMBC)患者中的预后价值。 方法: 收集接受根治性手术的3 628例PMBC患者的临床和随访资料,比较不同分期PMBC患者的乳腺癌特异性生存情况,通过AS和PS模型下的似然比卡方(LR χ(2))、赤池信息准则(AIC)和一致性指数(C-index)评估第8版AJCC分期在PMBC中的预后价值。 结果: 在PMBC中,肿瘤大小(P=0.002)、淋巴结状态(P=0.002)、组织学分级(P=0.003)、孕激素状态(P=0.017)及是否接受辅助放疗(P=0.040)与BCSS有关。与AS相比,1 326例(37.54%)患者的PS发生了改变,其中分期上升和分期下降的患者分别占总人群的6.50%和31.04%。AS和PS各期患者的BCSS差异均有统计学意义(均P<0.001)。AS模型和PS模型的LR χ(2)分别为16.41和17.50,差异无统计学意义(P=0.296);AIC分别为357.44和358.35;C-index分别为0.72和0.73,差异无统计学意义(P=0.667)。 结论: 第8版AJCC分期中的AS和PS均是PMBC患者预后的影响因素,但与AS相比,PS并无更强的预后预测能力。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ding SN, Wu JY, Chen WG, et al. [The predicting value of the 8th edition of American Joint Committee on Cancer staging manual in mucinous breast cancer]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31770854. doi:10.3760/cma.j.issn.0253-3766.2019.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。